Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/28883
Title: Inhibiting β-Amyloid-Associated Alzheimer’s Pathogenesis In Vitro and In Vivo by a Multifunctional Dimeric Bis(12)-hupyridone derived from its natural analogue
Authors: Hu, S
Wang, R
Cui, W
Zhang, Z 
Mak, S
Xu, D
Choi, C
Tsim, KW
Carlier, PR
Lee, M
Han, Y 
Keywords: Alzheimer’s disease
Aβ fibrils
Bis(12)-hupyridone
Cell viability
Memory impairment
Thioflavin T
Issue Date: 2015
Publisher: Springer New York LLC
Source: Journal of molecular neuroscience, 2015, v. 55, no. 4, p. 1014-1021 How to cite?
Journal: Journal of Molecular Neuroscience 
Abstract: Fibrillar aggregates of β-amyloid protein (Aβ) is the main constituent of senile plaques and considered to be one of the causative events in the pathogenesis of Alzheimer’s disease (AD). Compounds that could inhibit the formation of Aβ fibrils and block Aβ fibrils-associated toxicity may have therapeutic potential to combat AD. Bis(12)-hupyridone (B12H) is a multifunctional homodimer derived from huperzine A, which is an anti-AD drug in China. In the current study, the inhibitory effect of B12H on the formation of Aβ fibrils and their associated toxicity was investigated both in vitro and in vivo. By using Thioflavin T fluorescence assay, we found that B12H (0.3–3 μM) directly inhibited Aβ fibrils formation following co-incubation of B12H and Aβ1–40 at 37 °C for 6 days in vitro. However, huperzine A, at the same concentrations, did not show significant inhibitory effect on Aβ1–40 fibrils formation. Moreover, B12H markedly reduced Aβ1–40-induced cytotoxicity in cultured SH-SY5Y cells, as evidenced by the increase in cell viability, the decrease in lactate dehydrogenase release, and the reduction of apoptotic nuclei. Most importantly, B12H (0.2 and 0.4 mg/kg) reduced intracerebroventricular Aβ1–40 infusion-induced cognitive and memory impairments in rats, as evidenced by the decrease in escape latency and the increase in the spatial bias in Morris water maze test along with increasing choline acetyltransferase activity and decreasing acetylcholinesterase activity. Collectively, our study provided novel sights into the potential application of B12H in AD treatment.
URI: http://hdl.handle.net/10397/28883
ISSN: 1052-6234
DOI: 10.1007/s12031-014-0458-5
Appears in Collections:Journal/Magazine Article

Access
View full-text via PolyU eLinks SFX Query
Show full item record

SCOPUSTM   
Citations

8
Last Week
0
Last month
1
Citations as of Aug 14, 2017

WEB OF SCIENCETM
Citations

8
Last Week
0
Last month
Citations as of Aug 14, 2017

Page view(s)

40
Last Week
1
Last month
Checked on Aug 20, 2017

Google ScholarTM

Check

Altmetric



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.